LEC 1 Trademark
Trademark Overview
On Friday, January 17, 1975, a trademark application was filed for LEC 1 with the United States Patent and Trademark Office. The USPTO has given the LEC 1 trademark a serial number of 73042013. The federal status of this trademark filing is EXPIRED as of Monday, August 12, 1996. This trademark is owned by AMERICAN LECITHIN COMPANY. The LEC 1 trademark is filed in the Pharmaceutical Products category with the following description:
LECITHIN CONCENTRATE FOR USE IN LIPID DEFICIENCIES OR DERANGEMENT WHERE ITS ADMINISTRATION IS INDICATED
General Information
| Serial Number | 73042013 |
| Word Mark | LEC 1 |
| Filing Date | Friday, January 17, 1975 |
| Status | 900 - EXPIRED |
| Status Date | Monday, August 12, 1996 |
| Registration Number | 1024081 |
| Registration Date | Tuesday, November 4, 1975 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | LECITHIN CONCENTRATE FOR USE IN LIPID DEFICIENCIES OR DERANGEMENT WHERE ITS ADMINISTRATION IS INDICATED |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 018 |
| Class Status Code | 9 - Expired |
| Class Status Date | Monday, August 12, 1996 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, August 22, 1974 |
| First Use In Commerce Date | Thursday, August 22, 1974 |
Trademark Owner History
| Party Name | AMERICAN LECITHIN COMPANY |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | ATLANTA, GA 30302 |
Trademark Events
| Event Date | Event Description |
| Monday, August 12, 1996 | EXPIRED SEC. 9 |
| Monday, June 29, 1981 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
